VEGFR2 Expression in Head and Neck Squamous Cell Carcinoma Cancer Cells Mediates Proliferation and Invasion |
Xu, Hui-Min
(Department of Otolaryngology-Head and Neck Surgery, Changshu No.1 People's Hospital Affiliated to Soochow University)
Zhu, Jian-Guo (Department of Otolaryngology-Head and Neck Surgery, Changshu No.1 People's Hospital Affiliated to Soochow University) Gu, Lian (Department of Otolaryngology-Head and Neck Surgery, Changshu No.1 People's Hospital Affiliated to Soochow University) Hu, Song-Qun (Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of Nantong University) Wu, Hao (Department of Otolaryngology-Head and Neck Surgery, Affiliated Hospital of Nantong University) |
1 | Beck B, Driessens G, Goossens S, et al (2011). A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature, 478, 399-403. DOI |
2 | Bergers G, Benjamin LE (2003). Tumorigenesis and the angiogenic switch. Nat Rev Cancer, 3, 401-10. DOI |
3 | Brekken RA, Thorpe PE (2001). Vascular endothelial growth factor and vascular targeting of solid tumors. Anticancer Res, 21, 4221-9. |
4 | Cheng GZ, Zhang W, Wang LH (2008). Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Res, 68, 957-60. DOI |
5 | Corlu A, Loyer P (2012). Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication. Int J Hepatol, 2012, 689324. |
6 | Croci DO, Rabinovich GA (2014). Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference. Oncoimmunol, 3, 29380. DOI |
7 | Das LC, Karrison TG, Witt ME, et al (2014). Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades. Ann Oncol. |
8 | Folkman J, Shing Y (1992). Angiogenesis. J Biol Chem, 267, 10931-4. |
9 | Gasparini G, Longo R, Toi M, et al (2005). Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol, 2, 562-77. |
10 | Guo S, Colbert LS, Fuller M, et al (2010). Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta, 1806, 108-21. |
11 | Inglehart RC, Scanlon CS, D'Silva NJ (2014). Reviewing and reconsidering invasion assays in head and neck cancer. Oral Oncol, 50, 1137-43. DOI |
12 | Kauppila JH, Korvala J, Siirila K, et al (2014). Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. J Oral Pathol Med. |
13 | Kontic M, Milovanovic J, Colovic Z, et al (2014). Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. |
14 | Krajewska J, Handkiewicz-Junak D, Jarzab B (2015). Sorafenib for the treatment of thyroid cancer: an updated review. Expert Opin Pharmacother, 1-11. |
15 | Lichtenberger BM, Tan PK, Niederleithner H, et al (2010). Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell, 140, 268-79. DOI |
16 | Mokhtari S (2012). Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma. Diagn Pathol, 7, 6. DOI |
17 | Parast CV, Mroczkowski B, Pinko C, et al (1998). Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis. Biochemistry, 37, 16788-801. DOI |
18 | Pathare SM, Gerstung M, Beerenwinkel N, et al (2011). Clinicopathological and prognostic implications of genetic alterations in oral cancers. Oncol Lett, 2, 445-51. DOI |
19 | Rehman AO, Wang CY (2009). CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int J Oral Sci, 1, 105-18. DOI |
20 | Reya T, Clevers H (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843-50. DOI |
21 | Rothenberg SM, Ellisen LW (2012). The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest, 122, 1951-7. DOI |
22 | Xuan ZX, Li LN, Zhang Q, et al (2014). Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth. Int J Oncol, 45, 2411-20. DOI |
23 | Schulze WX, Deng L, Mann M (2005). Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol, 1, 2005-8. |
24 | Segiet OA, Michalski M, Brzozowa-Zasada M, et al (2015). Angiogenesis in primary hyperparathyroidism. Ann Diagn Pathol. |
25 | Silva SR, Bowen KA, Rychahou PG, et al (2011). VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer, 128, 1045-56. DOI |
26 | Ye F, Chen HZ, Xie X, et al (2004). Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells. Gynecol Oncol, 94, 125-33. DOI |
![]() |